A new study reveals that delta opioid receptor agonist KNT-127 has a rapid and effective antidepressant effect with minimal side effects. The research highlights the molecular mechanisms underlying its action, including mTOR signaling pathways and Akt activation in the medial prefrontal cortex.
A research tool developed at the Garvan Institute has uncovered unprecedented detail about pancreatic cancer drug response and resistance. The molecule AKT, a key driver of cancer growth and spread, is activated in distinct parts of the tumour, including areas of low oxygen supply where it forms pockets of resistance to therapy.
Researchers at Moffitt Cancer Center have discovered that hyperactivation of Akt and overexpression of IKBKE occur in 50 percent of human cancers. These findings suggest that targeting the inhibition of Akt may be an effective therapeutic strategy for treating breast cancer.
Researchers discover that rapamycin blocks abnormal tumor-like blood vessel formation by inhibiting Akt signaling, a key player in tumor growth. This finding suggests a potential clinical utility for rapamycin as an anti-angiogenic agent and opens up a new pathway for rapamycin's therapeutic action.
Researchers found that NF-kappaB links growth factor signaling with proto-oncogenes Myc, Akt, and Ras. The molecular mechanism regulates cell growth and death, providing a built-in protection against cancer.